TIGER BIO NEWDEALTIGER BIO NEWDEALTIGER BIO NEWDEAL

TIGER BIO NEWDEAL

No trades
See on Supercharts

Key stats

Assets under management (AUM)
‪111.13 B‬KRW
Fund flows (1Y)
‪18.50 B‬KRW
Dividend yield (indicated)
0.23%
Discount/Premium to NAV
−1.3%

About TIGER BIO NEWDEAL

Issuer
Mirae Asset Global Investments Co., Ltd.
Brand
Tiger ETF
Expense ratio
0.40%
Home page
Inception date
Oct 6, 2020
Index tracked
KRX Bio K-New Deal Index - KRW - Benchmark TR Gross
Management style
Passive
ISIN
KR7364970004
The purpose of managing investment trust properties is to use the KRX Bio K-New Deal Index announced by the Korea Exchange as the underlying index so that the rate of change in net asset value per share is similar to the rate of change in the underlying index.

Classification

Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Pharma, biotech & life sciences
Strategy
Vanilla
Weighting scheme
Market cap
Selection criteria
Market cap

Returns

1 month3 monthsYear to date1 year3 years5 years
Price performance
NAV total return

What's in the fund

As of May 23, 2024
Exposure type
StocksBonds, Cash & Other
Health Technology
Stocks99.77%
Health Technology98.96%
Distribution Services0.80%
Bonds, Cash & Other0.23%
Cash0.23%
Stock breakdown by region
100%
Asia100.00%
North America0.00%
Latin America0.00%
Europe0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings

Dividends

Dividend payout history

Assets under management (AUM)

Fund Flows